BofA downgraded Westlake (WLK) to Neutral from Buy with a price target of $87, up from $86. The stock is fairly-valued when balancing persistent challenges in Performance and Essential Materials, PEM, segment against solid Housing and Infrastructure Products profitability, the analyst tells investors in a research note. The firm is also reducing its 2025 and 2026 EBITDA estimates to $1.28B and $1.605B from $1.34B and $1.80B previously on lower PEM earnings, BofA added.
TipRanks Cyber Monday Sale
- Claim 60% off TipRanks Premium for data-backed insights and research tools you need to invest with confidence.
- Subscribe to TipRanks' Smart Investor Picks and see our data in action through our high-performing model portfolio - now also 60% off
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on WLK:
- Westlake price target lowered to $90 from $94 at Truist
- Westlake price target lowered to $90 from $92 at Mizuho
- Westlake price target lowered to $93 from $100 at Citi
- Westlake Corporation: Hold Rating Amid Revised Earnings, Market Challenges, and Inflationary Pressures
- JPMorgan healthcare analysts hold an analyst/industry conference call